Cenobamate Shows Promise for Children with Tumor-Related Epilepsy

Summary

A recent study looked at how well cenobamate, a medication already used for focal epilepsy, works for children with tumor-related epilepsy (TRE). This is important because TRE can be hard to treat, especially when other medications don’t help.

In this study, 17 children with TRE were given cenobamate as an additional treatment. Before starting the medication, these children had an average of 12 seizures a month. After treatment, this number dropped to about 3 seizures a month, which is a significant improvement. About 24% of the children became seizure-free, and 41% had at least half as many seizures as before.

Importantly, no side effects were reported for those who were also receiving chemotherapy, which is good news for families concerned about combining treatments. The study found that a child’s previous treatment history didn’t help predict how well cenobamate would work for them.

This research suggests that cenobamate could be a helpful option for families dealing with tumor-related epilepsy, offering hope for better seizure control. While more studies are needed to confirm these findings, it’s encouraging news for parents looking for effective treatments for their children.

Original study: Read on source